Human Papillomavirus (HPV) will affect over 80% of sexually active people in their lifetime.
The Gardasil-9 vaccine prevents 90% of HPV-related cancers.
Human Papillomavirus (HPV) is a group of over 200 related viruses. They are categorized based on risk:
Most infections clear on their own within 1–2 years, but the high-risk ones require active screening.
HPV is highly contagious and spreads through direct contact.
Symptoms vary significantly depending on the HPV strain.
Flesh-colored small bumps or clusters (cauliflower-like appearance).
Usually painless but may itch or bleed.
Appear weeks or months after exposure.
No symptoms until pre-cancerous cells or cancer develops.
Detected proactively via Pap smear or HPV DNA test (Screening is key!).
The Gardasil-9 vaccine offers the highest level of protection against the most dangerous HPV types.
| Feature | Details |
|---|---|
| Protects against | 9 High-Risk Types (including 6, 11, 16, 18) that cause over 90% of related cancers. |
| Prevents | 90% of Cervical Cancer 90% of Anal Cancer 90% of Genital Warts |
| Dosing Schedule | 2 doses (if starting age 9–14) 3 doses (if starting age 15–45) |
| Best Protection | Before first sexual contact, but still highly effective afterward. |
| Available at Irys | Same-day vaccination available upon request. |
We offer various effective, discreet treatment options for visible HPV warts.
Freezes warts for easy removal.
Quick in-office procedure with minimal scarring.
Precise surgical removal for larger, persistent warts.
Performed under local anesthesia.
Prescription creams like Imiquimod (Aldara) or Podophyllotoxin solution applied by the patient.
We achieve 90–95% clearance with personalized or combination therapy protocols.
Focused services for patients at highest risk of HPV-related cancer:
Pap smear alone every 3 years (ages 21–29).
Pap smear + HPV test every 5 years (ages 30–65).
Routine visual exam by a doctor for genital/anal warts.
Anal Pap smear screening if specifically indicated by risk factors.